Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Leukemia in Relapse”

1,814 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,814 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05199051
What this trial is testing

Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML

Who this might be right for
AMLLeukaemia (Acute Myeloid)
Centre Antoine Lacassagne 19
Early research (Phase 1)Looking for participantsNCT06880354
What this trial is testing

A Clinical Study to Evaluate the Safety and Efficacy of CLL1 and CD38 Dual-Target CAR-T Cell Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 37
Early research (Phase 1)Looking for participantsNCT06445803
What this trial is testing

CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHL

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed RemissionB-cell Lymphoma Refractory+1 more
Rong Tao 48
Testing effectiveness (Phase 2)Study completedNCT00003270
What this trial is testing

Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Roswell Park Cancer Institute 20
Early research (Phase 1)UnknownNCT05223686
What this trial is testing

To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL.

Who this might be right for
Acute Lymphoblastic Leukemia
Hrain Biotechnology Co., Ltd. 18
Testing effectiveness (Phase 2)Looking for participantsNCT05211570
What this trial is testing

AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in RelapseMyelodysplastic Syndrome Acute Myeloid Leukemia
AB Science 78
Testing effectiveness (Phase 2)Ended earlyNCT05361057
What this trial is testing

Efficacy of Venetoclax Based Regimen in Prevention Relapse of Consecutive MRD Positive AML Patients

Who this might be right for
Acute Myeloid LeukemiaMeasurable Disease
Institute of Hematology & Blood Diseases Hospital, China 20
Early research (Phase 1)Study completedNCT00006098
What this trial is testing

PS-341 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT06351306
What this trial is testing

DEC-C and Thioguanine for R/R AML

Who this might be right for
Acute Myeloid Leukemia
Columbia University
Not applicableStudy completedNCT05597085
What this trial is testing

Patients Who Received Inotuzumab Ozogamicin for B-cell ALL (Acute Lymphoblastic Leukemia) That Occurred Again After the Last Treatment

Who this might be right for
Adult Relapsed/Refractory B Cell Acute Lymphoblastic Leukemia
Pfizer 32
Testing effectiveness (Phase 2)UnknownNCT05066958
What this trial is testing

Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT

Who this might be right for
Acute Myeloid LeukemiaHigh Risk Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia, in Relapse+4 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 20
Early research (Phase 1)Looking for participantsNCT04243785
What this trial is testing

BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Edgewood Oncology Inc. 80
Testing effectiveness (Phase 2)Ended earlyNCT01620216
What this trial is testing

Targeted Therapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeChronic Myelomonocytic LeukemiaRecurrent Acute Lymphoblastic Leukemia+3 more
OHSU Knight Cancer Institute 12
Testing effectiveness (Phase 2)UnknownNCT03825367
What this trial is testing

Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML

Who this might be right for
AML, Childhood
Therapeutic Advances in Childhood Leukemia Consortium 13
Testing effectiveness (Phase 2)Looking for participantsNCT05601726
What this trial is testing

First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult Patients

Who this might be right for
Acute Myeloid Leukemia, AdultMyelodysplastic Syndromes
Advanced BioDesign 36
Testing effectiveness (Phase 2)Study completedNCT00003255
What this trial is testing

Carboplatin Plus Topotecan in Treating Patients With Relapsed Acute Myelogenous Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 38
Early research (Phase 1)Study completedNCT02543879
What this trial is testing

Study of a Novel BET Inhibitor FT-1101 in Patients With Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Myelogenous LeukemiaMyelodysplastic Syndrome+1 more
Forma Therapeutics, Inc. 94
Early research (Phase 1)Study completedNCT04017546
What this trial is testing

CYC065 CDK Inhibitor and Venetoclax Study in Relapsed/Refractory AML or MDS

Who this might be right for
AMLMDS
Cyclacel Pharmaceuticals, Inc. 14
Early research (Phase 1)WithdrawnNCT05519527
What this trial is testing

STI-6129 CD38 ADC for the Treatment of Patients With Relapsed or Refractory Systemic ALL Amyloidosis

Who this might be right for
Refractory T Acute Lymphoblastic LeukemiaAcute Myeloid Leukemia (AML)
M.D. Anderson Cancer Center
Early research (Phase 1)WithdrawnNCT06474663
What this trial is testing

A Phase I Study Investigating the Combination of Cladribine, Low Dose Cytarabine and Sorafenib Alternating With Decitabine in Pediatric Relapsed and Refractory Acute Leukemias

Who this might be right for
Refractory Acute LeukemiaRelapsed Acute Leukemia
M.D. Anderson Cancer Center
Load More Results